Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Queen Elizabeth Hospital trials SensiumVitals

21st Apr 2015 07:01

RNS Number : 7714K
Toumaz Limited
21 April 2015
 

21 April 2015

 

Toumaz Limited

Queen Elizabeth Hospital Birmingham trials SensiumVitals®

Toumaz Limited (AIM: TMZ, 'Toumaz', or 'the Group'), a pioneer in low-power, wireless semiconductor technologies for healthcare and digital audio, announces that SensiumVitals®, its wearable vital signs monitoring system, is to be trialled by the Queen Elizabeth Hospital Birmingham (QEHB), part of the University Hospitals Birmingham NHS Foundation Trust.

SensiumVitals® is a wireless system which takes readings of heart rate, respiration and temperature every two minutes with the data sent wirelessly to clinicians via hospital IT systems.  The system will initially be used in two wards: a post-surgery ward and an ambulatory care ward.

SensiumVitals® is being installed and fully integrated with the hospital's IT systems this month with the trial due to start in May. It is expected to last for about two months, during which time over 100 patients will be monitored by the system.

Funding for this commercial trial has been provided by the Queen Elizabeth Hospital Birmingham Charity.

Anthony Sethill, CEO of Toumaz Group, said:

"It is a significant development for us to be deploying SensiumVitals® in one of the UK's leading NHS hospitals.

"Our early trials with other hospitals in the US and the UK have shown that SensiumVitals® improves patient care, shortens hospital stays and reduces healthcare costs."

Mr. Ravinder Vohra, Clinical Lecturer - General Surgery of Queen Elizabeth Hospital Birmingham, said:

"SensiumVitals® has the potential to be a ground-breaking system in the world of patient monitoring. The ability to take measurements between routine observation rounds allows clinicians quickly to identify early signs of patient deterioration."

Enquiries:

 

Toumaz Limited

+44 (0)20 7391 0630

Anthony Sethill, Chief Executive Officer

Jonathan Apps, Chief Financial Officer

Instinctif Partners

+44 (0)20 7457 2020

Adrian Duffield/Lauren Foster

 

About SensiumVitals®

 

SensiumVitals® is an ultra-low power system for wireless monitoring of patient vital signs. Readings are taken every two minutes and the data is sent wirelessly and securely to clinicians via hospital IT systems.

 

The key benefit of SensiumVitals® is to provide clinicians with timely warnings of patient deterioration. This allows them to make earlier interventions, which in turn leads to shorter stays in hospital and lower healthcare costs.

 

The system also enables patients to be monitored whilst moving around freely within the hospital - a further factor in aiding swift recovery. The system is currently used in general wards and Accident & Emergency patient waiting areas - with future potential for broader hospital and in-home applications.

 

About Toumaz (www.toumaz.com)

Toumaz Limited is a pioneer in low-power, wireless semiconductor and software technologies for healthcare and consumer audio. The company has two divisions, Sensium Healthcare and Frontier Silicon. Sensium Healthcare develops wireless solutions for patient monitoring. Frontier Silicon provides chips, modules and software for digital radio and connected audio devices.

 

About Queen Elizabeth Hospital Birmingham

Queen Elizabeth Hospital Birmingham (QEHB) is run by University Hospitals Birmingham NHS Foundation Trust (UHB), providing clinical services to nearly 800,000 patients every year. It is recognised as one of the leading hospitals in Europe with an international reputation for quality of care, informatics/IT, clinical training and research. It is a regional centre for cancer, trauma, renal dialysis, burns and plastics, and has the largest solid organ transplantation programme in Europe. The Trust has the largest kidney programme in the UK, is a major specialist centre for burns and plastic surgery, and neurosciences, and has a specialist cancer centre. UHB provides a series of highly specialist cardiac, liver, oncology and neurosurgery services to patients from across the UK. QEHB is world-renowned for its trauma care and has developed pioneering surgical techniques in the management of ballistic and blast injuries, including bespoke surgical solutions for previously unseen injuries. As a result of its clinical expertise in treating trauma patients and military casualties, QEHB has been designated both a Level 1 Trauma Centre and host of the UK's only £20m National Institute for Health Research (NIHR) Surgical Reconstruction and Microbiology Research Centre (SRMRC).

 

About Queen Elizabeth Hospital Birmingham Charity

Queen Elizabeth Hospital Birmingham Charity is the official charity of the Queen Elizabeth Hospital. The charity's mission is to see an improvement in the health and wellbeing of the community through the services provided by University Hospital Birmingham NHS Foundation Trust and to improve the experiences of all the people who use the Trust's hospitals in any capacity. Queen Elizabeth Hospital Birmingham Charity supports medical and health research and encourages excellence in healthcare for patients and carers, wholly or mainly through the services provided by University Hospital Birmingham NHS Foundation Trust.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDBLFLEZFEBBK

Related Shares:

FST.L
FTSE 100 Latest
Value8,554.80
Change23.19